> > Phenylketonuria (PKU), Cefalo: "Today it's possible to build a full and active life...

Phenylketonuria (PKU), Cefalo: "Today it's possible to live a full and active life."

Phenylketonuria (PKU), Cefalo: "Today it's possible to live a full and active life."

(Adnkronos) - "Phenylketonuria is a genetic disease caused by a gene mutation that causes a deficiency of a very important enzyme—phenylalanine hydroxylase—which converts phenylalanine into byproducts, causing an accumulation of this essential amino acid. It is a disease...

(Adnkronos) – "Phenylketonuria is a genetic disease caused by a gene mutation that causes a deficiency of a very important enzyme—phenylalanine hydroxylase—which converts phenylalanine into byproducts, causing a buildup of this essential amino acid. It is a rare disease, but the incidence in newborns is approximately one case in 10 births in Europe, and in Italy it is even slightly higher.

Elevated levels of phenylalanine in the blood become toxic and compromise neurological, physical, and psychomotor development. To maintain the concentration of this essential amino acid at physiological, or at least adequate, levels, diet therapy has historically been used, which obviously remains the cornerstone of treatment for this disease. Recently," he continues, "other therapeutic options have also emerged on the therapeutic scene."

Since it's a storage disease, "early diagnosis is essential to initiate a phenylalanine-restricted diet. Starting effective therapy in pre-adolescents or adolescents leads to greater compliance with treatment and follow-up, and a better quality of life," explains Graziella Cefalo, pediatrician and head of the Rare Diseases Unit at the Santi Paolo e Carlo Asst, Milan. (VIDEO) 

“New therapies allow patients with phenylketonuria to maintain adequate levels of this essential amino acid, perhaps even by abandoning their diet, which in any case has a significant impact on their quality of life.

The fact that we will soon have the opportunity to administer this type of therapy to adolescent patients, that is, from 12 years of age and up, will allow, I believe, and some data have already confirmed it, greater adherence to dietary and drug therapy. When blood phenylalanine levels are adequate, patients themselves tell us that they feel much better, that they perform better in their studies, at work, and also in their relationships with others, they feel less anxious, have fewer difficulties concentrating, and that they have a much greater desire to live their lives to the fullest and make plans.” This is how Graziella Cefalo explains the impact of new therapeutic approaches, such as pegvaliase—a drug already authorized for the treatment of the condition, which recently received an extension of its therapeutic indications from the European Commission (EMA) to include patients with phenylketonuria (PKU) aged 12 years and older—on the condition. 

Before the introduction of newborn screening, "there was no early diagnosis, and subjects with phenylketonuria presented very serious psycho-intellectual and neurological disabilities, such as severe epilepsy," Cefalo points out. "High phenylalanine levels cause greater damage in children under 10-12 years of age because the nervous system is still maturing. This is precisely why it was once believed that diet therapy was sufficient until adolescence. However, it was later discovered that this is not actually the case. Keeping levels under control is crucial throughout life because, even in adults, they don't have such a serious impact on neurological and neurocognitive development, but they still have a significant impact on executive functions, concentration, and anxiety." Having high levels of this amino acid "means depression, anxiety, difficulty concentrating, difficulty relating to others, and difficulty at work," she explains. "Now we know that if a patient is now an adult and perhaps stopped dieting when they were 20 or 18, and is now 30, if they resume the diet, they regain all the functions they no longer had. The problem is that often, the patient, especially if they have stopped treatment for a long time, doesn't realize they have this 'fogginess,' this cognitive fog. Only when they start a new treatment and their levels go down, do they feel reborn."  

The therapeutic approach has changed significantly over the years. "For younger children, diet therapy is absolutely essential; parents adhere to the instructions and the children are monitored," Cefalo emphasizes. "When they reach 12 to 15 years of age, their social life expands and it becomes difficult to maintain the very strict diet they follow. Therefore, having the option of therapies that allow them to broaden the types of foods they can eat and, in some cases, even abandon the diet altogether, is truly a paradigm shift in the lives of these kids. If they keep their phenylalanine levels under control, they live absolutely normal lives. We have kids who have college degrees," he concludes, "and they have very important positions in the workplace, they have their own families, children: an absolutely normal life, but the levels must be monitored." 

News

webinfo@adnkronos.com (Web Info)

Continue on the app The news of your city, in real time.
Open in app App Store